Cyclization Cascades to Access Bioactive Diterpenoids
环化级联以获得生物活性二萜类化合物
基本信息
- 批准号:10217197
- 负责人:
- 金额:$ 39.71万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-08-01 至 2023-07-31
- 项目状态:已结题
- 来源:
- 关键词:Actinic keratosisAddressAlkenesAnti-Infective AgentsAntimalarialsAntineoplastic AgentsAntioxidantsAntiviral AgentsArchitectureAreaArtemisininsBicyclingBindingBiochemicalBiologicalBiological AssayBiologyBreathingCellsChemicalsChemistryChlorineCholesterolClinicalComplexCyclizationCytotoxinDevelopmentDiterpenesDockingEpoxy CompoundsEquilibriumEvolutionFamilyGoalsGuanineHIVHIV-1HealthHumanHydrazonesInvestigationKidney DiseasesLaboratoriesLeadLifeMalignant NeoplasmsMethodologyMethodsModernizationMolecularNatural ProductsNatureOrganic ChemistryPaclitaxelPharmaceutical PreparationsPolyenesProblem SolvingProcessProductionPropertyProtein BiosynthesisProtein Synthesis InhibitionRNA BindingReactionRecording of previous eventsRenal carcinomaResearchRibosomal InteractionRibosomesSavingsStructureStructure-Activity RelationshipSynthesis ChemistryTerpenesTimeTranslationsWorkanaloganti-cancerbasebioactive natural productscell killingchemical synthesiscompactincytotoxicdesignempoweredinhibitor/antagonistinnovationnovelosteoclastogenesispre-clinicalreactivation from latencysmall moleculestructural biologysuccesstool
项目摘要
Project Summary
Polycyclic terpenoid natural products are endowed with a broad range of medicinally relevant biological
activities. Taxol and artemisinin are two premier examples of life-saving terpenoids; the former is used clinically
to treat several cancers, while the latter is a critical antimalarial agent used worldwide. Chemical synthesis
approaches to natural products provide opportunities to make compounds that might be scarcely available
from nature, to generate analogues that are only available by total synthesis, and to make probe molecules for
increased understanding of the underlying biology. A balance of innovative strategy and new chemical
methodology promises efficient syntheses of small molecules that can provide answers to important biological
questions that are not easily solved by other means.
As part of our laboratory's long-term goal to enhance efficiency in the synthesis of complex natural
products to facilitate important studies in biology, the objective of the proposed research is to develop concise
and creative synthesis designs and empowering methodological advances to permit access to many bioactive
diterpenoid natural products. The rationale for this work is that synthetic chemistry is critical to the development
of natural product “hit molecules” into legitimate preclinical lead compounds by analogue production, by
identification of structure-activity relationships, by the synthesis of chemical probe molecules for mechanism of
action studies, and more. An efficient total synthesis of targeted natural products provides a platform from
which to address each of these key areas of research. Our specific aims include (1) the synthesis of the
lissoclimide family of cytotoxic translation inhibitors, to aid in refining our understanding of the molecular basis
of protein synthesis inhibition using biological and biochemical assays, as well as the tools of structural biology;
(2) the application of methodology developed for the lissoclimides to develop efficient syntheses of a range of
other complex, polycyclic diterpenoids; and (3) the development of new radical bicyclization strategies for the
synthesis of two architecturally complex anti-infective natural products.
The proposed research is significant because chemical synthesis will provide access to a broad range of
biologically important secondary metabolites and analogues with which to interrogate key processes; at the
same time, the underlying synthesis designs and methodologies will lead to vertical advancement of the field of
organic chemistry. These contributions are innovative by virtue of the chemistry-driven, multi-faceted
investigations into the mechanism of ribosome inhibition by the lissoclimides, the development of new
stereocontrolled polyene cyclization strategies to access particularly challenging diterpenoid natural products,
and the elaboration of new radical bicyclization strategies to make complex polycyclic architectures relevant to
bioactive natural products.
项目总结
项目成果
期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Synthesis of a Complex Brasilicardin Analogue Utilizing a Cobalt-Catalyzed MHAT-Induced Radical Bicyclization Reaction.
- DOI:10.1021/acs.orglett.3c01019
- 发表时间:2023-05-19
- 期刊:
- 影响因子:5.2
- 作者:Niman SW;Buono R;Fruman DA;Vanderwal CD
- 通讯作者:Vanderwal CD
Stereocontrolled Synthesis and Structural Revision of Plebeianiol A.
- DOI:10.1021/acs.orglett.1c03791
- 发表时间:2021-12-17
- 期刊:
- 影响因子:5.2
- 作者:Johnson LK;Niman SW;Vrubliauskas D;Vanderwal CD
- 通讯作者:Vanderwal CD
The Recurring Roles of Chlorine in Synthetic and Biological Studies of the Lissoclimides.
- DOI:10.1021/acs.accounts.0c00866
- 发表时间:2021-03-02
- 期刊:
- 影响因子:18.3
- 作者:Pak BS;Supantanapong N;Vanderwal CD
- 通讯作者:Vanderwal CD
Enantioselective Syntheses of Wickerols A and B.
- DOI:10.1021/jacs.3c00448
- 发表时间:2023-03-22
- 期刊:
- 影响因子:15
- 作者:Chung, Jonathan;Capani, Joseph S.;Goehl, Matthias;Roosen, Philipp C.;Vanderwal, Christopher D.
- 通讯作者:Vanderwal, Christopher D.
Stereocontrolled Radical Bicyclizations of Oxygenated Precursors Enable Short Syntheses of Oxidized Abietane Diterpenoids.
- DOI:10.1021/jacs.0c13300
- 发表时间:2021-02-24
- 期刊:
- 影响因子:15
- 作者:Vrubliauskas D;Gross BM;Vanderwal CD
- 通讯作者:Vanderwal CD
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Christopher D Vanderwal其他文献
Christopher D Vanderwal的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Christopher D Vanderwal', 18)}}的其他基金
Chemical Synthesis of Bioactive Diterpenoids
生物活性二萜类化合物的化学合成
- 批准号:
10405930 - 财政年份:2022
- 资助金额:
$ 39.71万 - 项目类别:
Cyclization Cascades to Access Bioactive Diterpenoids
环化级联以获得生物活性二萜类化合物
- 批准号:
9753289 - 财政年份:2018
- 资助金额:
$ 39.71万 - 项目类别:
Structural Elucidation, Synthesis and Study of the Chlorosulfolipids
氯磺脂的结构解析、合成与研究
- 批准号:
7788733 - 财政年份:2010
- 资助金额:
$ 39.71万 - 项目类别:
Structural Elucidation, Synthesis and Study of the Chlorosulfolipids
氯磺脂的结构解析、合成与研究
- 批准号:
8011218 - 财政年份:2010
- 资助金额:
$ 39.71万 - 项目类别:
Structural Elucidation, Synthesis and Study of the Chlorosulfolipids
氯磺脂的结构解析、合成与研究
- 批准号:
8401523 - 财政年份:2010
- 资助金额:
$ 39.71万 - 项目类别:
Structural Elucidation, Synthesis and Study of the Chlorosulfolipids
氯磺脂的结构解析、合成与研究
- 批准号:
8600291 - 财政年份:2010
- 资助金额:
$ 39.71万 - 项目类别:
Structural Elucidation, Synthesis and Study of the Chlorosulfolipids
氯磺脂的结构解析、合成与研究
- 批准号:
8207970 - 财政年份:2010
- 资助金额:
$ 39.71万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 39.71万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 39.71万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 39.71万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 39.71万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 39.71万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 39.71万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 39.71万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 39.71万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 39.71万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 39.71万 - 项目类别:
Research Grant














{{item.name}}会员




